(Q61933825)
Statements
Transdermal Lisuride: a Double-blind, Randomized, Active- and Placebo-controlled Multi-centre Phase III Efficacy Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) (English)
0 references
300
0 references
18 year
0 references
80 year
0 references